Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Jw, Baars"'
Autor:
Jj, Oudejans, Nm, Jiwa, Ja, Kummer, Gj, Ossenkoppele, van Heerde P, Jw, Baars, Pm, Kluin, Johanna Cornelia Kluin-Nelemans, Pj, Diest, Jm, Middeldorp, Cj, Meijer
Publikováno v:
Europe PubMed Central
Although the results of treatment of Hodgkin's disease (HD) have improved considerably in the last decades, the disease remains fatal in a minority of patients. We have recently shown that numbers of activated cytotoxic T cells (CTLs), present in tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::184cd5195f529b7025b54a4303cb1453
https://pubmed.ncbi.nlm.nih.gov/9226192
https://pubmed.ncbi.nlm.nih.gov/9226192
Autor:
Vliek S; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Hilbers FS; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mandjes I; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kessels R; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kleiterp S; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lips EH; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mulder L; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kayembe MT; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Loo CE; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Russell NS; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vrancken Peeters MTFD; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Surgery, Amsterdam University Medical center, Amsterdam, The Netherlands., Holtkamp MJ; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schot M; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Baars JW; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Honkoop AH; Department of Internal Medicine, Isala Klinieken, Zwolle, The Netherlands., Vulink AJE; Division of Medical Oncology, Reinier de Graaf Hospital, Delft, The Netherlands., Imholz ALT; Department of Internal Medicine, Deventer Ziekenhuis, Deventer, The Netherlands., Vrijaldenhoven S; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands., van den Berkmortel FWPJ; Department of Oncology, Zuyderland Medisch Centrum, Heerlen-Geleen, The Netherlands., Meerum Terwogt JM; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., Schrama JG; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands., Kuijer P; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van der Padt-Pruijsten A; Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands., Wesseling J; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Gilhuijs KGA; Image Sciences Institute, University Medical Center Utrecht, Utrecht, Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Nederlof P; Department of Molecular diagnostics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.linn@nki.nl.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.linn@nki.nl.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. s.linn@nki.nl.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2023 Sep 09; Vol. 9 (1), pp. 75. Date of Electronic Publication: 2023 Sep 09.
Autor:
van der Meulen M; Department of Neuro-Oncology, Erasmus MC Cancer Institute, Brain Tumor Center, University Medical Center, Rotterdam, The Netherlands. Electronic address: m.vandermeulen.2@erasmusmc.nl., Bakunina K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Cull G; Haematology Department, Sir Charles Gairdner Hospital and PathWest Laboratory Medicine, Nedlands, Australia; University of Western Australia, Crawley, Australia., Stevens WBC; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Baars JW; Department of Hemato-Oncology, Antoni van Leeuwenhoek Hospital/Dutch Cancer Institute, Amsterdam, The Netherlands., Mason KD; Department of Hematology, Royal Melbourne Hospital, Melbourne, Australia., Beeker A; Department of Hematology, Spaarne Gasthuis, Haarlem, The Netherlands., Beijert M; Department of Radiotherapy, University Medical Center Groningen, Groningen, The Netherlands., Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands., van den Bent MJ; Department of Neuro-Oncology, Erasmus MC Cancer Institute, Brain Tumor Center, University Medical Center, Rotterdam, The Netherlands., Issa S; Department of Hematology, Middlemore Hospital, Auckland, New Zealand., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Bromberg JEC; Department of Neuro-Oncology, Erasmus MC Cancer Institute, Brain Tumor Center, University Medical Center, Rotterdam, The Netherlands., Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Aug; Vol. 31 (8), pp. 1046-1055. Date of Electronic Publication: 2020 May 03.
Autor:
Bromberg JEC; Department of Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands. Electronic address: j.bromberg@erasmusmc.nl., Issa S; Department of Hematology, Middlemore Hospital, Auckland, New Zealand., Bakunina K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands., Seute T; Department of Neurology, University Medical Center Utrecht, Utrecht, Netherlands., Durian M; Department of Hematology, ETZ Hospital, Tilburg, Netherlands., Cull G; Haematology Department, Sir Charles Gairdner Hospital and PathWest Laboratory Medicine, Nedlands, WA, Australia; University of Western Australia, Crawley, WA, Australia., Schouten HC; Department of Hematology, University Medical Center, Maastricht, Netherlands., Stevens WBC; Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., Zijlstra JM; Department of Hematology, Amsterdam UMC-Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Baars JW; Department of Hemato-Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, Netherlands., Mason KD; Department of Hematology, Royal Melbourne Hospital, Melbourne, VIC, Australia., Beeker A; Department of Hematology, Spaarne Gasthuis, Haarlem, Netherlands., van den Bent MJ; Department of Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Beijert M; Department of Radiotherapy, University Medical Center Groningen, Groningen, Netherlands., Gonzales M; Department of Anatomical Pathology, Royal Melbourne Hospital, Melbourne, VIC, Australia., de Jong D; Department of Pathology, Amsterdam UMC-Vrije Universiteit Amsterdam, Amsterdam, Netherlands; HOVON Pathology Facility and Biobank, Amsterdam, Netherlands., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Feb; Vol. 20 (2), pp. 216-228. Date of Electronic Publication: 2019 Jan 07.
Autor:
Oosten LEM; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. l.e.m.oosten@lumc.nl.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands. l.e.m.oosten@lumc.nl., Chamuleau MED; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Thielen FW; Erasmus School of Health Policy & Management / Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands., de Wreede LC; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands., Siemes C; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Internal Medicine, Deventer Hospital, Deventer, The Netherlands., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Smeekes OS; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Kersten MJ; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Hardi L; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.; Department of Internal Medicine, Alrijne Hospital, Leiderdorp, The Netherlands., Baars JW; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Demandt AMP; Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands., Stevens WBC; Department of Hematology, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., van Imhoff GW; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Brouwer R; Department of Hematology, Reinier de Graaf Hospital, Delft, The Netherlands., Uyl-de Groot CA; Erasmus School of Health Policy & Management / Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands., Kluin PM; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Jong D; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Annals of hematology [Ann Hematol] 2018 Feb; Vol. 97 (2), pp. 255-266. Date of Electronic Publication: 2017 Dec 06.
Autor:
Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Imhoff GW; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., van der Holt B; HOVON Data Center, Erasmus MC Cancer Institute-Clinical Trial Center, Rotterdam, The Netherlands., Schouten HC; Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands., Schaafsma MR; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., MacKenzie MA; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Baars JW; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Kersten MJ; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van den Bent MJ; Department of Neuro-oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Enting RH; Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands., Spoelstra FM; HOVON Data Center, Erasmus MC Cancer Institute-Clinical Trial Center, Rotterdam, The Netherlands., Poortmans P; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Bromberg JEC; Department of Neuro-oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Hematological oncology [Hematol Oncol] 2017 Dec; Vol. 35 (4), pp. 497-503. Date of Electronic Publication: 2016 Aug 17.
Autor:
Gerards MC; MC Slotervaart, Amsterdam, The Netherlands. Electronic address: m.c.gerards@amc.uva.nl., van der Velden DL; Antoni van Leeuwenhoek Hospital/Dutch Cancer Institute, Amsterdam, The Netherlands., Baars JW; Antoni van Leeuwenhoek Hospital/Dutch Cancer Institute, Amsterdam, The Netherlands., Brandjes DPM; MC Slotervaart, Amsterdam, The Netherlands., Hoekstra JBL; Academic Medical Center, Amsterdam, The Netherlands., Vriesendorp TM; Isala, Zwolle, The Netherlands., Gerdes VEA; MC Slotervaart, Amsterdam, The Netherlands.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2017 May; Vol. 113, pp. 235-241. Date of Electronic Publication: 2017 Mar 10.
Autor:
Persoon S; Academic Medical Center, University of Amsterdam, Department of Rehabilitation, the Netherlands. Electronic address: s.persoon@amc.uva.nl., Kersten MJ; Academic Medical Center, University of Amsterdam, Department of Hematology, the Netherlands. Electronic address: m.j.kersten@amc.uva.nl., Buffart LM; VU University Medical Center, Department of Epidemiology and Biostatistics and the EMGO+ Institute for Health and Care Research, Amsterdam, the Netherlands. Electronic address: l.buffart@vumc.nl., Vander Slagmolen G; De Sportartsen Groep, locatie Amsterdam, the Netherlands. Electronic address: g.vanderslagmolen@amc.uva.nl., Baars JW; Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Division of Medical Oncology, Department of Hematology, the Netherlands. Electronic address: j.baars@nki.nl., Visser O; VU University Medical Center, Department of Hematology, the Netherlands. Electronic address: o.visser@vumc.nl., Manenschijn A; Isala, Department of Oncology, Dr. Van Heesweg 2, the Netherlands. Electronic address: j.manenschijn@isala.nl., Nollet F; Academic Medical Center, University of Amsterdam, Department of Rehabilitation, the Netherlands. Electronic address: f.nollet@amc.uva.nl., Chinapaw MJM; VU University Medical Center, Department of Public and Occupational Health and the EMGO+ Institute for Health and Care Research, the Netherlands. Electronic address: m.chinapaw@vumc.nl.
Publikováno v:
Journal of science and medicine in sport [J Sci Med Sport] 2017 Feb; Vol. 20 (2), pp. 116-122. Date of Electronic Publication: 2016 Feb 08.
Autor:
Thijssen R, Ter Burg J, van Bochove GG, de Rooij MF, Kuil A, Jansen MH, Kuijpers TW, Baars JW, Virone-Oddos A, Spaargaren M, Egile C, van Oers MH, Eldering E, Kersten MJ, Kater AP
Publikováno v:
Leukemia [Leukemia] 2016 Sep; Vol. 30 (9), pp. 1963.
Autor:
Wouters H; a Department of Pharmacy, Unit of Pharmacotherapy and Pharmaceutical Care, Groningen Research Institute of Pharmacy, Faculty of Mathematics and Natural Sciences , University of Groningen , Groningen , The Netherlands., Baars JW; b Department of Medical Oncology , Netherlands Cancer Institute , Amsterdam , The Netherlands., Schagen SB; c Department of Psychosocial Research and Epidemiology , Netherlands Cancer Institute , Amsterdam , The Netherlands.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2016 Sep - Oct; Vol. 55 (9-10), pp. 1121-1125. Date of Electronic Publication: 2016 Jun 22.